Fortress Biotech, Inc. (FBIOP) Financials
FBIOP Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 356.9 million | 154.5 million |
| Dec. 31, 2025 | 185.5 million | 123.4 million |
| Sept. 30, 2025 | 181.4 million | 116.2 million |
| June 30, 2025 | 159.9 million | 122.5 million |
FBIOP Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | 203.9 million | 1.8 million |
| Dec. 31, 2025 | -12.5 million | 2.5 million |
| Sept. 30, 2025 | -6.1 million | 3.2 million |
| June 30, 2025 | -27.6 million | 16.8 million |
FBIOP Net Income
No data available :(
FBIOP Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 255.8 million | 36.9 million | 12.0 million |
| Dec. 31, 2025 | 79.4 million | 59.5 million | 14.8 million |
| Sept. 30, 2025 | 86.2 million | 47.8 million | 14.9 million |
| June 30, 2025 | 74.4 million | 50.0 million | 15.4 million |
FBIOP Shares Outstanding
FBIOP Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | - | 540000 | 15.9 million | - |
| Dec. 31, 2025 | - | -367000 | 14.7 million | - |
| Sept. 30, 2025 | - | 208000 | 17.4 million | - |
| June 30, 2025 | - | 8.1 million | 38.8 million | - |
FBIOP Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 16.0 million | 7.3 million |
| Dec. 31, 2025 | 16.1 million | 5.4 million |
| Sept. 30, 2025 | 17.6 million | 5.8 million |
| June 30, 2025 | 16.4 million | 4.9 million |
FBIOP Revenue by Segment
Graph available only for paid members. Upgrade to see it.
FBIOP
Price: $20.25
52 week price:
Dividend Yield: 11.32%
5-year range yield:
Payout Ratio: -271.56%
Payout Ratio Range:
Earnings Per Share: -0.86 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 15415
Market Capitalization: 162.7 million
Average Dividend Frequency: 12